23
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Dyspepsia?Acid or Stress? A Study of Controversy: Abandoned by Experts, Finalized in Clinical Practice?

Pages 1057-1064 | Published online: 08 Jul 2009

References

  • Brante T, Norman H. Epidemisk masspsykos eller reell risk? En sociologsk studie av kontroversen kring elöverkänslighet. (Epidemic mass psychosis or a real risk? A sociologic study of the controversy on hypersensitivity against electricity.) Stockholm: Brutus Östlings Bökforlag Symposion; 1995.
  • Molinder H, Wallander M, Svardsudd K, Bodemar G. The introduction of H2-receptor antagonists to Scandinavia. Effects of experts’ opinions. Scand J Gastroenterol 1998;33:224–30.
  • Sjödin I. Psychotherapy in peptic ulcer disease [dissertation]. Göteborg: University of Göteborg; 1983.
  • Molinder H. Scandinavian views on non surgical treatment of peptic ulcer. Scand J Gastroenterol 1995;30:721–30.
  • Peterson H. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043–8.
  • Adami H-O, Agents I, Nyrén O, Gustavsson S, Lööf L, Nyberg A. The clinical diagnosis of ‘gastritis’. Scand J Gastroenterol 1984;19:216–9.
  • Krag E. Pseudo-ulcer and true peptic ulcer. Acta Med Scand 1965;178(Fasc 6):713–28.
  • Bendtsen F, Dano P, Guldhammer B, Remvig L, Krogsöe O. Cimetidinbehandling af rontgennegative dyspepsi. (Cimetidine therapy in radio-negative dyspepsia. English summary.) Ugeskr Laeger 1983;145:3090–3.
  • Berstad A, Hausken T, Haug T. Funksjonell dyspepsi—en stressjukdom. (Functional dyspepsia—a manifestation of stress. English summary.) TidsskrNor Laegeforen 1992;112:1603–4.
  • Nyrén O, Adami H-O, Gustavsson S, Lindgren PG, Lööf L, Nyberg A. Epigastric distress syndrome. J Clin Gastroenterol 1987;9:303–9.
  • Gotthard R, Bodemar G, Brodin U, Jönsson K-Å. Treatment with cimetidine, antacid or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988;23:7–18.
  • Möller-Hansen J Dyspepsia in primary care [dissertation]. Odense: Odense University; 1996.
  • Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gatsroenterology 1995;109:671–80.
  • Nörrelund N, Helles A, Schmiegelow M, Jacobsen F, Nielsen HOW, Kjaerulff E, et al. Ukarakteristik dyspepsi i almen praksis. (Uncharacteristic dyspepsia in general practice. English summary.) Ugeskr Laeger 1980;142:1750–3.
  • Weberg R, Berstad A. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomised double blind trial. Scand J Gastroenterol 1988;23:237–43.
  • Kelbaek H, Linde J, Eriksen J, Munksgaard S, Moesgaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985;217:281–7.
  • Schaffalitzky de Muckadell O. Peptisk ulcus og ulcusdyspepsi. (Peptic ulcer and ulcer dyspepsia.) Ugeskr Laeger 1997;159:3745.
  • Nyrén O Non-ulcer dyspepsia [dissertation]. Uppsala: University of Uppsala; 1985.
  • Nyrén O, Adami HO, Bates S, Bergström R, Gustavsson S, Lööf L, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986;314:339–43.
  • Nyrén O, Adami HO, Gustavsson S, Lööf L. Excess sick-listing in nonulcer dyspepsia. J Clin Gastroenterol 1986;8:339–45.
  • Haug T, Wilhelmsen I, Ursin H, Berstad A. What are the real problems for patients with functional dyspepsia? Scand J Gastroenterol 1995;30:97–100.
  • Jörgensen LS, Bönlökke L, Christensen N. Life strain, life events, and autonomic response to a psychological stressor in patients with chronic upper abdominal pain. Scand J Gastroenterol 1986;21:605–13.
  • Johnsen R, Straume B, Förde OH. Peptic ulcer and non-ulcer dyspepsia—a disease and a disorder. Scand J Prim Health Care 1988;6:239–43.
  • Berstad A, Hauksen T, Gilja O, Hveem K, Underland KA, Wilhelmsen J, et al. Gastric accommodation in functional dyspepsia. Scand J Gastroenterol 1997;32:193–7.
  • Haug T, Wilhelmsen I, Svebak S, Berstad A, Ursin H. Psychotherapy in functional dyspepsia. J Psychosom Res 1994;38:735–44.
  • Johannessen T. Funksjonell dyspepsi (Functional dyspepsia). TidsskrNor Laegefor 1992;112:1568–9.
  • Tanum L, Malt UF. A new pharmacological treatment of functional gastrointestinal disorder. A double-blind placebocontrolled study with mianserin. Scand J Gastroenterol 1996;31: 318–25.
  • Gotthard R, Bodemar G, Jönsson K-Å. Diagnostic outcome in patients with dyspepsia. A preliminary report. Scand J Gastroenterol 1987;22 Suppl 128:86–9.
  • Klauser AG, Voderholzer WA, Knesewitsch PA, Schindelbesk NE, Muller-Lissner SA. What is behind dyspepsia? Dig Dis Sci 1993;38:147–54.
  • Nesland A, Berstad A. Effect of cimetidine in patients with nonulcer dyspepsia and erosive prepyloric changes. Scand J Gastroenterol 1985;20:629–35.
  • Kleveland P, Larsen S, Sandvik L, Kristensen P, Johannesen T, Hafstad PE, et al. The effect of cimetidine in non ulcer dyspepsia. Experience with a multi cross-over model. Scand J Gatroenterol 1985;20:19–24.
  • Johannessen T, Fjøsne U, Kleveland P, Halvorsen T, Kristensen P, Løge I, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988;23:327–36.
  • Farup P, Hovde Ø, Breder O. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patientswith non-ulcer dyspepsia responding to treatment with ranitidine? Scand J Gastroenterol 1995;30:829–32.
  • Bytzer P. Medikamentell behandling af non-ulcus dyspepsi. (Medicinal treatment of non-ulcer dyspepsia. English summary.) Ugeskr Laeger 1991;153:2212–6.
  • Colin-Jones D. Management of dyspepsia. Report of a working party. Lancet 1988;1:576–9.
  • Talley N, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145–60.
  • Möller-Hansen J, Bytzer P, Schaffalitzky de Munkatell O. Managment of dyspeptic patients in primary care. Scand J Gastroenterol 1998;33:799–805.
  • Talley N, Weaver A, Tesmer D, Zinsmeister A. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993;105:1378–86.
  • Bytzer P, Møller-Hansen J, Schaffalitzky de Muckadell OB, Malcow-Møller A. Predicting endoscopic diagnosis in the dyspeptic patient. Scand J Gastroenterol 1997;32:118–25.
  • Larsen S, Farup P, Flaten O, Osnes M. The multi-crossover model for classifying patients as responders to a given treatment. Scand J Gastroenterol 1991;26:763–70.
  • Johannessen T Controlled trials in single subjects [dissertation] Trondheim: University of Trondheim; 1992.
  • Johannessen T. Controlled trials in single subjects. Br Med J 1991;303:173–4.
  • Farup PG, Wetterhus S, Osnes M, Ulshagen K. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia. Scand J Gastroenterol 1997;32:755–9.
  • Kristensen P, Sandbakken P, Johannessen T, Løge I, Hafstad PE, Petersen H, et al. Fordøyelsessykdommer i almenpraksis. (Gastrointestinal diseases in general practice.) Tidsskr Nor Laegeforen 1985;105:728–31.
  • Nyrén O, Lindberg G, Lindstrom E, Marke L-Å, Seensalu R. Economic costs of functional dyspepsia. Pharm Econom 1992; 1:312–24.
  • Nyrén O. Treatment of non-ulcer dyspepsia. In: Thorén L, Ljunggren H, Beerman B, Lönnerholm G, editors. Pharmacological treatment of ulcer and non-ulcer dyspepsia. Uppsala: Swedish National Board of Health and Welfare. Drug Information Committee, Sweden; 1985. p. 97–109.
  • Experts’ group. Non-ulcer dyspepsia. In: Thoren l, Ljunggren H, Beerman B, Lönerholm G, editors. Pharmacological treatment of ulcer and non-ulcer dyspepsia. Uppsala: National Board of Health and Welfare. Drug Information Committee, Sweden; 1984. p. 160–1.
  • Lindberg G, Lindström E, Marke L, Nordlund A, Nyrén O. Gatroskopi—vid utredning av ont i magen. (Gastroscopy—in investigation of abdominal pain.) Stockholm: The Swedish Council on Technology Assessment in Health Care; 1990.
  • Kristensen K. Denmark: H2 antagonists over the counter. Lancet 1992;339:418.
  • Järhult B. Cimetidinbehandling i öppen vård. (Cimetidine therapy in outpatient care. English summary.) Lakartidningen 1980;77:45–8.
  • Rosell A. Tagamet (cimetidin) i Aijeplog. (Tagamet (cimetidine) in Arjeplog.) Lakartidningen 1978;75:4012.
  • Rosén A, Strandberg K. Tagamet och den obundna lakemedels informationen. (Tagamet and the uncommitted information of drugs.) Lakartidningen 1978;75:4461.
  • Lidén E. Undermedicin orsakar depression-njurskador (Wonderdrug causes depression and kidney-damage.) Dala-Demokraten 1978 Nov.;08:5.
  • Grundström E. Varning for vanlig magsårsmedicin. (Warning against a common drug for peptic ulcer.) Dagens Nyheter 1981 Oct.;9:12.
  • Nilsson M. Pillret som drabbar de svenska industriarbetarna. (The pill that hits the Swedish workers.) Metallarbetaren 1980; (11):16–8.
  • Jöberger B. Mirakelmedicin mot magkatarr. (Wonder drug against gastritis.) Dagens Nyheter 1978 Oct.;18:3–4.
  • Thürmer HL, Flaaten B, Erichsen K, Lid N, Solheim S. Helicobacter pylori infection in non-ulcer dyspeptic and ulcer patients. Scand J Gastroenterol 1996;31: 744–8.
  • Nyrén O. Functional dyspepsia: is gastric acid and/or Helicobacter pylori infection involved in the aethiology? Eur J Gastroenterol Hepatol 1992;4: 608–14.
  • Bernersen B, Johnsen R, Bostad L, Straume B, Sommer A-I, Burhol PG. Is Helicobacter pylori the cause of dyspepsia? Br Med J 1992;304:1276–79.
  • Agréus L. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. Scand J Gastroenterol 1995;30:752–7.
  • Bytzer P. Diagnosing dyspepsia: any controversies left? Gastroenterology 1996;110:302–6.
  • Krag E. Gastro-ösofagealt reflukssyndrom. (Gastro-oesophageal reflux-syndrrome.) In: Thaysen JH, Chistensen LK, Lorenzen I, editors. Medicinsk kompendium. Vol 1. 13th ed. Copenhagen: Nyt Nordisk Forlag; 1986. p. 1120–23.
  • Joelsson B, Johnsson F. Heartburn-the acid test. Gut 1989;30: 1523–5.
  • Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987;22:714–8.
  • Klauser A, Schindbleck N, Muller-Lissner S. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335:205–8.
  • Nissen A. Mavesårspraeparater: forbrug, priser og tilskud för og efter den 27.3.1989. (Drugs for peptic ulcer. Expentiture, prices and reimbursement before and after March 27 1989.) Ugeskr Laeger 1991;153: 1536–37.
  • Ahnfeldt-Møllerup I, Fly G, Knudsen MH. Dyspepsi i almen praxis. (Dyspepsia in general practice. English summary.) Ugeskr Laeger 1997;159:3772–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.